SCHEMBL12376481

SCHEMBL12376481

c1ccc2cc(-c3cc4ccccc4s3)ncc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.54
CYP19A1 P11511 1/20 0.51
CYP11B1 P15538 1/20 0.49
CYP11B2 P19099 1/20 0.49
APP P05067 2/20 0.46
NPC1 O15118 2/20 0.46
PDPK1 O15530 1/20 0.46
DCK P27707 1/20 0.45
RAB9A P51151 1/20 0.44
CYP1A2 P05177 2/20 0.41
MAPKAPK2 P49137 1/20 0.41
HSD17B1 P14061 1/20 0.41
HSD17B2 P37059 1/20 0.41
KDM4E B2RXH2 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
BTK Q06187 1/20 0.41
IKBKB O14920 2/20 0.41
CYP2A6 P11509 1/20 0.41
CHUK O15111 1/20 0.41
IKBKG Q9Y6K9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24404648 0.83 KDM1A (0.51) KDM1ACYP19A1CYP11B1CYP11B2APP
SCHEMBL20911051 0.80 NPC1 (0.39) KDM1ACYP19A1CYP11B1CYP11B2NPC1
SCHEMBL20911049 0.80 NPC1 (0.39) KDM1ACYP19A1CYP11B1CYP11B2NPC1
SCHEMBL4014804 0.78 KDM1A (0.57) KDM1ACYP19A1CYP11B1CYP11B2APP
SCHEMBL13017787 0.78 KDM1A (0.57) KDM1ACYP19A1CYP11B1CYP11B2APP
SCHEMBL4821816 0.78 KDM1A (0.57) KDM1ACYP19A1CYP11B1CYP11B2APP
SCHEMBL13201335 0.78 KDM1A (0.64) KDM1ACYP19A1CYP11B1CYP11B2APP
SCHEMBL28911362 0.78 KDM1A (0.57) KDM1ACYP19A1CYP11B1CYP11B2APP
SCHEMBL3134206 0.78 CYP19A1 (0.50) KDM1ACYP19A1CYP11B1CYP11B2APP
SCHEMBL4659871 0.77 KDM1A (0.56) KDM1ACYP19A1CYP11B1CYP11B2APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200227644-A1 ORGANIC LIGHT-EMITTING DIODE OPERABLE AT LOW VOLTAGE WITH HIGH EFFICIENCY AND LONG LIFETIME SFC CO., LTD. (KR) 2020-07-16 US disclosed
US-20180072753-A1 NOVEL ORGANIC HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DEVICE COMPRISING SAME SFC CO., LTD. (KR) 2018-03-15 US disclosed
US-20180072753-A1 NOVEL ORGANIC HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DEVICE COMPRISING SAME SFC CO., LTD. (KR) 2018-03-15 US disclosed
US-20110196104-A1 Norbornene-based copolymers with iridium complexes and exiton transport groups in their side-chains and use thereof GEORGIA TECH RESEARCH CORPORATION (US) 2011-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180072753-A1 NOVEL ORGANIC HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DEVICE COMPRISING SAME OR10J3, CRY1, NR2E3 KDM1A 367/4885CYP19A1 68/4885CYP11B1 790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.